A rapid screening test for the detection of MDMA (ecstasy) in biological samples. This test is used for drug of abuse screening in clinical and occupational monitoring.
Manufactured by
POCBio (Nexlab Co., Ltd.)
China
POCBio is a burgeoning manufacturer dedicated to providing point-of-care tests for in vitro diagnostic use. We seamlessly integrate R&D, manufacturing, and global distribution to deliver high-quality, affordable, and eco-friendly diagnostic kits. We are proficient in creating solutions for infectious diseases, chronic conditions, and wellness monitoring.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Chemtron Biotech Co.,Ltd.
China · 7 relevant products
NTBIO Diagnostics Inc.
Canada · 5 relevant products
Hangzhou Pefectech Biotechnology Co., Ltd.
China · 6 relevant products
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 24 relevant matches
Shanghai Chemtron Biotech Co.,Ltd. · China
A diagnostic test for detecting 3,4-methylenedioxymethamphetamine (MDMA) in biological samples, used for drug screening purposes.
Shanghai Chemtron Biotech Co.,Ltd. · China
A diagnostic test for the detection of ecstasy (MDMA) in drug screening applications. This test is part of Shanghai Chemtron Biotech's drugs of abuse testing portfolio.
Acmex Bio-Technology (Chongqing) Co.,Ltd · China
One-Step Ecstasy (MDMA) Test Kit is a rapid and convenient immunochromatographic assay for the qualitative detection of 3,4-Methylenedioxymethamphetamine (MDMA) and its metabolites in urine samples at or above the cutoff level of 500 ng/ml. The device is designed for over-the-counter use as well as professional use.
21 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products